What’s in the Specialty Pharmacy Pipeline? Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017. Creating a ‘robust’ specialty pharmacy network March 29, 2017 By Tracey Walker The correct approach to take when creating a specialty pharmacy network is a key issue for healthcare executives. Business Group Makes Price Recommendations for Specialty Drugs March 16, 2017 By Nicholas Hamm The high cost of specialty drugs demands a change in Washington, according to a report. ACA reform must preserve mental health pharmacy access March 12, 2017 By John Figueroa ACA repeal or replacement must focus on how to preserve mental health services and pharmacy access. New strategies for managing drug spend: RA, Cancer, Hep C March 04, 2017 By Mari Edlin The proliferation of specialty drugs has prompted new techniques for keeping costs in tow. Express Scripts’ 2016 Drug Trend Report: 7 things to know February 13, 2017 By Tracey Walker Report highlights spending trends in key areas, including specialty medications, oncology, diabetes, and inflammatory conditions. Top 5 Things to Know About Future Drug Spending January 24, 2017 By Christine Blank How will money be spent on medications in the next 5 years? Here's a look at the top trends. Integrating pharmacy benefit, medical benefit cuts costs November 29, 2016 By Tracey Walker Here’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs. Health execs must brace for autoimmune drug changes October 05, 2016 By Tracey Walker A comprehensive understanding of this rapidly increasing drug class is essential to integrate pharmacy and medical claim information. Five specialty pharmaceutical trends to watch October 05, 2016 By Aubrey Westgate Approvals of specialty pharmaceuticals have far outpaced traditional drugs, and that trend will continue. But that’s not the only specialty medication trend that healthcare executives should have on their radar.